[1] |
Li DM, Li RY, de Hoog GS, et al. Fatal Exophiala infections in China, with a report of seven cases[J]. Mycoses, 2011, 54(4): e136⁃142. DOI: 10.1111/j.1439⁃050 7.2010.01859.x.
|
[2] |
Chakrabarti A. Epidemiology of central nervous system mycoses[J]. Neurol India, 2007, 55(3): 191⁃197.
|
[3] |
Patel AK, Patel KK, Darji P, et al. Exophiala dermatitidis endocarditis on native aortic valve in a postrenal transplant patient and review of literature on E. dermatitidis infections[J]. Mycoses, 2013, 56(3): 365⁃372. DOI: 10.1111/myc.12009.
|
[4] |
Kondori N, Gilljam M, Lindblad A, et al. High rate of Exophiala dermatitidis recovery in the airways of patients with cystic fibrosis is associated with pancreatic insufficiency[J]. J Clin Microbiol, 2011, 49(3): 1004⁃1009. DOI: 10.1128/JCM.01899⁃10.
|
[5] |
Revankar SG, Sutton DA. Melanized fungi in human disease[J]. Clin Microbiol Rev, 2010, 23(4): 884⁃928. DOI: 10.1128/CMR.00019⁃10.
|
[6] |
Steinbach WJ, Singh N, Miller JL, et al. In vitro interactions between antifungals and immunosuppressants against Aspergillus fumigatus isolates from transplant and nontransplant patients[J]. Antimicrob Agents Chemother, 2004, 48(12): 4922⁃4925. DOI: 10.1128/AAC.48.12.4922⁃4925.2004.
|
[7] |
Sun S, Li Y, Guo Q, et al. In vitro interactions between tacrolimus and azoles against Candida albicans determined by different methods[J]. Antimicrob Agents Chemother, 2008, 52(2): 409⁃417. DOI: 10.1128/AAC.01070⁃07.
|
[8] |
Narreddy S, Manavathu E, Chandrasekar PH, et al. In vitro interaction of posaconazole with calcineurin inhibitors and sirolimus against zygomycetes[J]. J Antimicrob Chemother, 2010, 65(4): 701⁃703. DOI: 10.1093/jac/dkq020.
|
[9] |
陈淳, 陈启红, 孙毅, 等. 低浓度他克莫司与抗真菌药物联合的体外抗真菌效应[J].中国真菌学杂志, 2015, 10(4): 207⁃209. DOI: 10.3969/j.issn.1673⁃3827.2015.04.004.
|
[10] |
Clinical and Laboratory Standards Institute. CLSI document M38⁃A2 reference method for broth dilution antifungal susceptibility testing of filamentous fungi: approved standard[S]. USA: Wayne PA, 2008.
|
[11] |
Zhang J, Silao FG, Bigol UG, et al. Calcineurin is required for pseudohyphal growth, virulence, and drug resistance in Candida lusitaniae[J]. PLoS One, 2012, 7(8): e44192. DOI: 10.1371/journal.pone.0044192.
|
[12] |
Onyewu C, Eads E, Schell WA, et al. Targeting the calcineurin pathway enhances ergosterol biosynthesis inhibitors against Trichophyton mentagrophytes in vitro and in a human skin infection model[J]. Antimicrob Agents Chemother, 2007, 51(10): 3743⁃3746. DOI: 10.1128/AAC.00492⁃07.
|
[13] |
Onyewu C, Blankenship JR, Del PM, et al. Ergosterol biosynthesis inhibitors become fungicidal when combined with calcineurin inhibitors against Candida albicans, Candida glabrata, and Candida krusei[J]. Antimicrob Agents Chemother, 2003, 47(3): 956⁃964.
|
[14] |
Uppuluri P, Nett J, Heitman J, et al. Synergistic effect of calcineurin inhibitors and fluconazole against Candida albicans biofilms[J]. Antimicrob Agents Chemother, 2008, 52(3): 1127⁃1132. DOI: 10.1128/AAC.01397⁃07.
|
[15] |
Shirazi F, Kontoyiannis DP. The calcineurin pathway inhibitor tacrolimus enhances the in vitro activity of azoles against Mucorales via apoptosis[J]. Eukaryot Cell, 2013, 12(9): 1225⁃1234. DOI: 10.1128/EC.00138⁃13.
|